These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37698412)

  • 21. Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms.
    Neuner EA; Sekeres J; Hall GS; van Duin D
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5744-8. PubMed ID: 22926565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial.
    Rosso-Fernández C; Sojo-Dorado J; Barriga A; Lavín-Alconero L; Palacios Z; López-Hernández I; Merino V; Camean M; Pascual A; Rodríguez-Baño J;
    BMJ Open; 2015 Mar; 5(3):e007363. PubMed ID: 25829373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic treatment of acute uncomplicated cystitis based on rapid urine test and local epidemiology: lessons from a primary care series.
    Etienne M; Lefebvre E; Frebourg N; Hamel H; Pestel-Caron M; Caron F;
    BMC Infect Dis; 2014 Mar; 14():137. PubMed ID: 24612927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fosfomycin for urinary tract infections.
    Med Lett Drugs Ther; 1997 Jul; 39(1005):66-8. PubMed ID: 9255237
    [No Abstract]   [Full Text] [Related]  

  • 25. The effectiveness of nitrofurantoin, fosfomycin and trimethoprim for the treatment of cystitis in relation to renal function.
    Ten Doesschate T; van Haren E; Wijma RA; Koch BCP; Bonten MJM; van Werkhoven CH
    Clin Microbiol Infect; 2020 Oct; 26(10):1355-1360. PubMed ID: 32165321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux.
    Wu TH; Huang FL; Fu LS; Chou CM; Chien YL; Huang CM; Lin CF; Chen PY
    J Microbiol Immunol Infect; 2016 Oct; 49(5):717-722. PubMed ID: 25442872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of levofloxacin as a treatment for complicated urinary tract infections and pyelonephritis.
    Bientinesi R; Murri R; Sacco E
    Expert Opin Pharmacother; 2020 Apr; 21(6):637-644. PubMed ID: 32004097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZTI-01 (fosfomycin for injection) in the treatment of hospitalized patients with complicated urinary tract infections.
    Burgos RM; Rodvold KA
    Future Microbiol; 2019 Apr; 14():461-475. PubMed ID: 30854892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shortening duration of ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections: A retrospective study.
    Fink DL; Collins S; Barret R; Pollara G; Marks M; Logan S
    PLoS One; 2019; 14(9):e0223130. PubMed ID: 31557236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and treatment of community-acquired urinary tract infections in adults: what has changed. Comments on the 2008 guidelines of the French Health Products Safety Agency (AFSSAPS)].
    Caron F
    Presse Med; 2010 Jan; 39(1):42-8. PubMed ID: 19665343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection.
    Stein GE
    Clin Ther; 1999 Nov; 21(11):1864-72. PubMed ID: 10890258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection: A real-world perspective and review of the literature.
    Babiker A; Clarke L; Doi Y; Shields RK
    Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114856. PubMed ID: 31307867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections.
    Veve MP; Wagner JL; Kenney RM; Grunwald JL; Davis SL
    Int J Antimicrob Agents; 2016 Jul; 48(1):56-60. PubMed ID: 27234673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fosfomycin: A Revisited Antibiotic for Urinary Tract Infections.
    Parikh FS
    J Assoc Physicians India; 2017 Sep; 65(9):11. PubMed ID: 29313569
    [No Abstract]   [Full Text] [Related]  

  • 35. [The efficiency of combined regimens for the treatment of urinary tract infections in women using the herbal drug Canephron N].
    Shatylko TV; Gamidov SI; Popkov VM; A KY; Gasanov NG
    Urologiia; 2021 Dec; (6):51-56. PubMed ID: 34967165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
    Ten Doesschate T; van Mens SP; van Nieuwkoop C; Geerlings SE; Hoepelman AIM; Bonten MJM
    BMC Infect Dis; 2018 Dec; 18(1):626. PubMed ID: 30518334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.
    Fedrigo NH; Mazucheli J; Albiero J; Shinohara DR; Lodi FG; Machado ACDS; Sy SKB; Tognim MCB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Modern pharmacotherapy of uncomplicated infections of the lower urinary tract: the position of antibacterial and herbal preparations].
    Zyryanov SK; Butranova OI; Al-Ragawi A
    Urologiia; 2020 Apr; (2):76-84. PubMed ID: 32351068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experience of using fosfomycin for the treatment of acute uncomplicated cystitis in women in postpartum period].
    Kutluev MM; Safiullin RI
    Urologiia; 2019 Dec; (5):27-30. PubMed ID: 31808628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis and management of urinary tract infections in the outpatient setting: a review.
    Grigoryan L; Trautner BW; Gupta K
    JAMA; 2014 Oct 22-29; 312(16):1677-84. PubMed ID: 25335150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.